Opinion

Video

Impact of Treatment Delays on Patient Outcomes

Key Takeaways

  • Timely intervention in oncology is critical for improving survival rates, disease progression, and quality of life.
  • Delays in treatment can result in advanced disease stages, reduced treatment efficacy, and increased morbidity.
SHOW MORE

Toby Maher, MD, PhD, discusses how delays in treatment for idiopathic pulmonary fibrosis (IPF) can significantly worsen patient outcomes and accelerate disease progression, underscoring the critical need for timely intervention.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
4 KOLs are featured in this series
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo